Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cellectar Biosciences's market cap was $9.99M on Nov 11, 2026, against $11.46M a year earlier. Over the last 5 years it ranged from $6.14M to $102.49M, with a median of $15.20M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.99M | +6.0% |
| 2025 | Dec 31, 2025 | $9.42M | -22.4% |
| 2024 | Dec 31, 2024 | $12.13M | -55.9% |
| 2023 | Dec 29, 2023 | $27.48M | +163.0% |
| 2022 | Dec 30, 2022 | $10.45M | -74.2% |
| 2021 | Dec 31, 2021 | $40.58M | -27.3% |
| 2020 | Dec 31, 2020 | $55.78M | +164.1% |
| 2019 | Dec 31, 2019 | $21.12M | +219.1% |
| 2018 | Dec 31, 2018 | $6.62M | -64.2% |
| 2017 | Dec 29, 2017 | $18.46M | +182.0% |
| 2016 | Dec 30, 2016 | $6.55M | +17.1% |
| 2015 | Dec 31, 2015 | $5.59M | -76.1% |
| 2014 | Dec 31, 2014 | $23.36M | +9.6% |
| 2013 | Dec 31, 2013 | $21.31M | -33.3% |
| 2012 | Dec 31, 2012 | $31.97M | +169.1% |
| 2011 | Dec 30, 2011 | $11.88M | – |
See a number that looks wrong?